Therefore, gaining further insights into the connection between structure and function will be critical to refine and develop ongoing efforts to target LRRK2 in Parkinson's, for example by illuminating the allosteric consequences of kinase inhibition and the distinctions between structurally dissimilar compounds [36]. This evidence concerns the gene LRRK2 and Parkinsonism.